Trial Profile
A prospective long-term study to compare etanercept and adalimumab with methotrexate in patients with juvenile idiopathic arthritis.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jul 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Methotrexate
- Indications Juvenile rheumatoid arthritis
- Focus Adverse reactions
- 14 Jul 2015 New trial record